CIK 0000730272
- Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042729386
- Phone
- +1 781-449-9560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,976,580
- in 4 filings, $5.0M under 10b5-1 plans
Net −$4,976,580. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-18 | Cox John Director | Exercise or conversion · Stock Option (Right to Buy) | −14,000 | 0 | ||
| 2020-03-18 | Cox John Director | Exercise or conversion · Stock Option (Right to Buy) | −3,632 | 0 | ||
| 2020-03-18 | Cox John Director | Exercise or conversion · Stock Option (Right to Buy) | −3,366 | 0 | ||
| 2020-03-18 | Cox John Director | Exercise or conversion · Stock Option (Right to Buy) | −2,434 | 0 | ||
| 2020-03-18 | Cox John Director | Exercise or conversion · Stock Option (Right to Buy) | −3,304 | 0 | ||
| 2020-03-16 | RYAN THOMAS F JR Director | Exercise or conversion | +500 | $38.76 | $19K | 2,423 |
| 2020-03-16 | RYAN THOMAS F JR Director | Exercise or conversion | +500 | $42.07 | $21K | 2,923 |
| 2020-03-16 | RYAN THOMAS F JR Director | Sale | −1,000 | $91.48 | $91K | 1,923 |
| 2020-03-16 | RYAN THOMAS F JR Director | Exercise or conversion · Stock Option (Right to Buy) | −500 | 1,934 | ||
| 2020-03-16 | RYAN THOMAS F JR Director | Exercise or conversion · Stock Option (Right to Buy) | −500 | 0 | ||
| 2020-03-04 | Snodgres Jon Chief Financial Officer | Sale | −1,045 | $90.39 | $94K | 36,127 |
| 2020-03-04 | RYAN THOMAS F JR Director | Exercise or conversion | +1,992 | $41.19 | $82K | 3,915 |
| 2020-03-04 | RYAN THOMAS F JR Director | Exercise or conversion | +2,804 | $42.07 | $118K | 6,719 |
| 2020-03-04 | RYAN THOMAS F JR Director | Sale | −4,796 | $88.82 | $426K | 1,923 |
| 2020-03-04 | RYAN THOMAS F JR Director | Exercise or conversion · Stock Option (Right to Buy) | −1,992 | 0 | ||
| 2020-03-04 | RYAN THOMAS F JR Director | Exercise or conversion · Stock Option (Right to Buy) | −2,804 | 500 | ||
| 2020-03-04 | KURIYEL RALF Senior VP, R&D | Sale | −650 | $90.08 | $59K | 28,429 |
| 2020-03-04 | KURIYEL RALF Senior VP, R&D | Sale | −1,905 | $90.99 | $173K | 26,524 |
| 2020-03-04 | Cox John Director | Exercise or conversion | +10,000 | $12.91 | $129K | 12,781 |
| 2020-03-04 | Cox John Director | Sale | −10,000 | $93.39 | $934K | 2,781 |
Page 38 of 42 · 832 trades